The Carlat Psychiatry Podcast
Clear, engaging, and practical updates on clinical psychiatry. Hosted by Chris Aiken, MD, and Kellie Newsome, PMHNP.
Follow Our Podcast
Recent Episodes
The Choice: Meds for Tardive Dyskinesia
With two medications approved for tardive dyskinesia, how do you choose between them? And how does anyone afford their $80-140,000 a year price tag? We'll...
Getting Uncomfortable With Esketamine
Esketamine (Spravato) was approved in 2019 for treatment resistant depression, but the medicine quickly gathered controversy about its long-term safety....
Getting Uncomfortable With Esketamine
Esketamine (Spravato) was approved in 2019 for treatment resistant depression, but the medicine quickly gathered controversy about its long-term safety....
Getting Uncomfortable With Esketamine
Esketamine (Spravato) was approved in 2019 for treatment resistant depression, but the medicine quickly gathered controversy about its long-term safety....
Getting Uncomfortable With Esketamine
Esketamine (Spravato) was approved in 2019 for treatment resistant depression, but the medicine quickly gathered controversy about its long-term safety....
POWERED BY BLUBRRY
